Viewing Study NCT00126477



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126477
Status: COMPLETED
Last Update Posted: 2013-05-01
First Post: 2005-08-02

Brief Title: Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Study Overview

Official Title: The Quality of Life of Adult Survivors Who Received a Marrow Transplant as a Child
Status: COMPLETED
Status Verified Date: 2013-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Studying quality of life in cancer survivors may help determine the long-term effects of hematologic cancer and may help improve the quality of life for future cancer survivors

PURPOSE This clinical trial is studying the quality of life of adult cancer survivors who have undergone a previous bone marrow or peripheral stem cell transplant for a childhood hematologic cancer
Detailed Description: OBJECTIVES

Determine the extent to which adult cancer survivors who have undergone prior bone marrow or peripheral blood stem cell transplantation for a pediatric hematologic malignancy require ongoing health care and whether these needs change with increasing time after transplantation
Correlate physical capabilities body image physical limitations including sexuality issues which alter or influence lifestyle with time after transplantation in these patients
Determine whether cognitive abilities relative to memory and neurobehavioral ratings change with increasing time after transplantation in these patients
Correlate social and relationship abilities with length of time after transplantation in these patients

OUTLINE Patients and siblings complete a self-report quality of life questionnaire including outcome assessments of neuroendocrine function cognitive abilities physical capability and psychosocial behavior

PROJECTED ACCRUAL Approximately 750 patients 375 adult cancer survivors case group and 375 siblings control group will be accrued for this study within 7 years

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CDR0000434793 REGISTRY PDQ None
FHCRC-109800 None None None